Ramathibodi Hospital is a university hospital of the Faculty of Medicine Ramathibodi Hospital, Mahidol University. and is a hospital capable of super tertiary care. It is a teaching hospital for all undergraduate students of the Faculty of Medicine Ramathibodi Hospital.

There are 1,300 beds in Ramathibodi Hospital.

During the past decade, Ramathibodi Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ramathibodi Hospital" #1 sponsor was "Mahidol University" with 7 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored and "Chulalongkorn University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ramathibodi Hospital" #1 collaborator was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator, "Ministry of Health, Thailand" with 1 trials as a collaborator and "Mirror Biologics, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ramathibodi Hospital" are "Generalized Pustular Psoriasis" (2 trials), "Abdominal Compartment Syndrome" (1 trials), "Anesthesia" (1 trials), "Aspergillosis" (1 trials) and "Brugada Syndrome" (1 trials). Many other conditions were trialed in "Ramathibodi Hospital" in a lesser frequency.

Most popular intervention types in "Ramathibodi Hospital" are "Drug" (11 trials), "Biological" (2 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Spesolimab" (2 trials), "AlloStim® immunotherapy" (1 trials), "Andrographis Paniculata" (1 trials) and "Boesenbergia" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ramathibodi Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ramathibodi Hospital". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ramathibodi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ramathibodi Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".